Welcome to our dedicated page for Bravada Gold news (Ticker: BGAVD), a resource for investors and traders seeking the latest updates and insights on Bravada Gold stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bravada Gold's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bravada Gold's position in the market.
Bravada Gold (BGAVD) closed a non-brokered private placement on June 24, 2026, issuing 285,715 shares at $0.70 for gross proceeds of $200,000.50. The entire placement was acquired by the new President & CEO, Paul West-Sells.
The shares carry a hold period until October 23, 2026. Net proceeds will be used for general working capital. The financing is subject to final TSX Venture Exchange approval and is treated as a related party transaction under MI 61-101, with Bravada relying on valuation and minority approval exemptions.
Bravada Gold (BGAVD) provided an update on engineering work at its wholly owned Wind Mountain gold project in Nevada, advancing the project toward a Pre-Feasibility Study (PFS).
The company engaged specialist firms and plans an updated Preliminary Economic Assessment (PEA) incorporating new resources and costs, targeted for Q3 2026.
Bravada Gold (BGAVD) appointed Dr. Paul West-Sells as President, CEO and director, while Joseph A. Kizis Jr. becomes Vice President, Exploration and remains on the board.
Dr. West-Sells received 300,000 stock options at $0.92 and will invest $200,000 in a private placement of 285,715 shares at $0.70, subject to TSXV approval.
Bravada (BGAVD) has adopted semi-annual financial reporting under British Columbia Securities Commission Blanket Order 51-933 for eligible venture issuers. The company is moving from quarterly to semi-annual reporting to lower administrative and financial burdens while maintaining audited annual and six-month financial statements and MD&A.
Bravada’s fiscal year ends July 31; it will no longer file Q1 and Q3 interim reports and MD&A, starting with the nine-month period ended April 30, 2026. The company states it remains committed to transparency and timely disclosure of all material changes through news releases and material change reports.
Bravada (TSXV:BGAVD) announced the appointment of Adam Melnyk, P.Eng., CFA to its board of directors on March 11, 2026. Management cites his mine development, business development and financing experience as supporting the company’s Pre-feasibility Study on the Wind Mountain project in Nevada.
Bravada said Melnyk will work with management to de-risk Wind Mountain, advance a production decision, and explore the company’s portfolio of Nevada exploration assets.